Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Go Healthy Natural releases new line of Antioxidant Boost liquid multivitamins

Go Healthy Natural, a leader in liquid daily dose multivitamins, has announced the launch of their new line of "Antioxidant Boost" liquid multivitamins. The two ounce daily dose liquid multivitamins will be sold in cases of 24 bottles with free shipping and be featured on www.GoHealthyNatural.com and www.Amazon.com.

30 Dec 2015

York University announces establishment of Dahdaleh Insitute for Global Health

York University in Ontario, Canada this month announced the establishment of The Dahdaleh Institute for Global Health, in honour of Victor Dahdaleh - a prominent UK-based Canadian business leader and York alumnus who recently donated $20m to the University.

28 Dec 2015

Philadelphia jury ruled in favor of plaintiff against Johnson and Johnson

Fair Rate Funding, a leader in pelvic mesh lawsuit funding, reports a jury verdict in favor of the plaintiff, Patricia Hammons and against defendant, Johnson and Johnson on Monday.

26 Dec 2015

Personalized respiratory-motion system enables more precise lung cancer imaging

Lung cancer patients know that precise medical imaging can help a surgeon eradicate tumors and preserve healthy tissue.

24 Dec 2015

Samsung BioLogics celebrates groundbreaking of new biopharmaceutical manufacturing plant in Korea

Samsung BioLogics today celebrated the groundbreaking of its third plant in Incheon Free Economic Zone, Songdo, Korea. Joining the event were Samsung Electronics Vice Chairman Jay Y. Lee, Samsung BioLogics President & CEO Dr. TH Kim and over 500 attendees.

21 Dec 2015

Univercells awarded grant to reduce cost of vaccine manufacturing in the Walloon region

Univercells SA, a company that designs single-use cost-efficient bioprocess solutions for the next generation of biomanufacturing, today announces that it has received a grant from the Walloon region.

21 Dec 2015

Turing Pharmaceuticals emphasizes continued availability of Daraprim

Turing Pharmaceuticals AG, a privately-held biopharmaceutical company focused on developing and commercializing innovative treatments for serious diseases and conditions, today emphasizes the continued availability of Daraprim and cautions healthcare providers of proposed alternatives to Daraprim.

20 Dec 2015

LifeVest wearable cardioverter defibrillator approved for children at risk for sudden cardiac arrest

The U.S. Food and Drug Administration today approved a new indication for the LifeVest wearable cardioverter defibrillator. The LifeVest is approved for certain children who are at risk for sudden cardiac arrest, but are not candidates for an implantable defibrillator due to certain medical conditions or lack of parental consent.

17 Dec 2015

Wearable exoskeletons: what interactions are possible? An interview with Dr Juan C. Moreno

Wearable exoskeletons are coming to stay. Technological advancements in embedded computation and wearable mechatronics are enabling the production of new wearable exoskeletons that were not feasible a decade ago

17 Dec 2015

Novel material can provide protection against brain injuries

Funding has been awarded to world-leading, US-based helmet designer and manufacturer, Roy Burek of Charles Owen Inc., to develop a novel material created by researchers from Cardiff University's School of Engineering that can improve the safety of athletes, members of the military and others from brain injuries by better absorbing and dissipating impact.

17 Dec 2015

REGENSCIENTIFIC obtains CE-mark for Renú Soft Tissue (Volumizing) Implant

REGENSCIENTIFIC announced today that it has received the CE-mark (CE 630688) for the Renú Soft Tissue (Volumizing) Implant for Lipoatrophy, Vocal Fold Insufficiency and Soft Tissue Augmentation.

16 Dec 2015

Researchers find new way to prevent or reduce pathologies caused by malformed proteins

Improperly formed proteins can cause a host of serious illnesses, from muscular dystrophy to cystic fibrosis. A question of enormous import in research, beyond the challenge of determining how malformed proteins contribute to specific disease processes, is figuring out ways to prevent or reduce the pathologies they cause.

16 Dec 2015

WuXi forms strategic alliance with MedImmune to accelerate development of biologics portfolio in China

WuXi AppTec, a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device industries, announced today that it has formed a strategic alliance with MedImmune, the global biologics research and development arm of AstraZeneca.

16 Dec 2015

Four UC Santa Barbara engineers named 2015 NAI fellows

Four UC Santa Barbara engineers have been elected to the National Academy of Inventors for 2015. Recognized for their "highly prolific spirit of invention," professors John Bowers, Craig Hawker, Umesh Mishra and Galen Stucky are among the newest fellows elected by the organization.

16 Dec 2015

Egalet submits NDA for ARYMO ER (morphine sulfate) extended-release tablets

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, announced the company has submitted a new drug application (NDA) for ARYMO ER (morphine sulfate) extended-release tablets for the management of pain severe enough to require daily, around-the-clock opioid treatment and for which alternative treatments are inadequate.

15 Dec 2015

Validus, Wood Creek announce acquisition of U.S. rights to several Sanofi US products

Validus Pharmaceuticals LLC, together with Wood Creek Capital Management, LLC ("Wood Creek"), announced today the acquisition of the U.S. rights to several well-known product lines from Sanofi US: Anzemet (dolasetron mesylate) Injection and Tablets, Claforan (cefotaxime) Injection/IM/IV, Demerol (meperidine hydrochloride) Tablets, Drisdol (ergocalciferol) Capsules and Oral Solution, Hiprex (methenamine hippurate) Tablets, Lasix (furosemide) Tablets, Norpramin (desipramine hydrochloride) Tablets and Trental (pentoxifylline) Tablets.

14 Dec 2015

Egalet, Teva sign agreement to commercialize SPRIX Nasal Spray in Israel, Gaza and the West Bank

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, today announced a collaboration agreement with Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company.

14 Dec 2015

Complix signs agreement with Selexis to advance production of autoimmune drug candidate CMX-02

Complix NV, a biopharmaceutical company developing a pipeline of transformative protein therapeutics, called Alphabodies, for the treatment of cancer and severe autoimmune diseases, announces that it is advancing the development of CMX-02, a potential treatment of severe autoimmune disease.

14 Dec 2015

Combination treatment provides effective one-two punch against prostate cancer

Results from a long-term clinical trial conducted by cancer researchers at Houston Methodist Hospital show that combining radiation treatment with "suicide gene therapy," a technique in which prostate cancer cells are genetically modified so they signal a patient's immune system to attack them, provides a safe and effective one-two punch against the disease.

12 Dec 2015

FDA approves Teligent's sNDA for CEFOTAN (cefotetan) for Injection

Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's supplemental new drug application (sNDA) from the U.S. Food and Drug Administration (FDA) for CEFOTAN (cefotetan) for Injection.

11 Dec 2015

Manufacturing News and Research

Further Reading

Go Healthy Natural releases new line of Antioxidant Boost liquid multivitamins

York University announces establishment of Dahdaleh Insitute for Global Health

Philadelphia jury ruled in favor of plaintiff against Johnson and Johnson

Personalized respiratory-motion system enables more precise lung cancer imaging

Samsung BioLogics celebrates groundbreaking of new biopharmaceutical manufacturing plant in Korea

Univercells awarded grant to reduce cost of vaccine manufacturing in the Walloon region

Turing Pharmaceuticals emphasizes continued availability of Daraprim

LifeVest wearable cardioverter defibrillator approved for children at risk for sudden cardiac arrest

Wearable exoskeletons: what interactions are possible? An interview with Dr Juan C. Moreno

Novel material can provide protection against brain injuries

REGENSCIENTIFIC obtains CE-mark for Renú Soft Tissue (Volumizing) Implant

Researchers find new way to prevent or reduce pathologies caused by malformed proteins

WuXi forms strategic alliance with MedImmune to accelerate development of biologics portfolio in China

Four UC Santa Barbara engineers named 2015 NAI fellows

Egalet submits NDA for ARYMO ER (morphine sulfate) extended-release tablets

Validus, Wood Creek announce acquisition of U.S. rights to several Sanofi US products

Egalet, Teva sign agreement to commercialize SPRIX Nasal Spray in Israel, Gaza and the West Bank

Complix signs agreement with Selexis to advance production of autoimmune drug candidate CMX-02

Combination treatment provides effective one-two punch against prostate cancer

FDA approves Teligent's sNDA for CEFOTAN (cefotetan) for Injection

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®